Boris Sepesi

The University of Texas MD Anderson Cancer Center

Papers

8

Total Citations

285

H-Index

7

About

No biography available yet.

Research Focus

Medicine8 · 285 citations
Surgery7 · 283 citations
Internal medicine7 · 253 citations
Perioperative4 · 246 citations
Lung cancer6 · 244 citations
Cancer4 · 143 citations
Immunotherapy4 · 143 citations
Nivolumab3 · 141 citations
Ipilimumab3 · 141 citations
Neoadjuvant therapy3 · 141 citations
Pneumonectomy3 · 139 citations
Robotic surgery3 · 133 citations

Key Achievements

7
H-Index
8
Papers
285
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2019 (3 Papers)
🤝 Key Collaborators: 52
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
    Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
    94 citations · 2022
  2. 2
    Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience
    92 citations · 2019
  3. 3
    Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes
    32 citations · 2021
  4. 4
    OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
    28 citations · 2019
  5. 5
    Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
    19 citations · 2023
  6. 6
    Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection
    9 citations · 2023
  7. 7
    Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model
    9 citations · 2021
  8. 8
    Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?
    2 citations · 2019

Key Collaborators

RJReza J. Mehran7 shared papersSGStephen G. Swisher7 shared papersMBMara B. Antonoff7 shared papersDCDavid C. Rice7 shared papersWLWayne L. Hofstetter7 shared papersAAAra A. Vaporciyan6 shared papersRRRavi Rajaram5 shared papersJAJack A. Roth5 shared papersGLGarrett L. Walsh5 shared papersTCTina Cascone4 shared papersWNWilliam N. William3 shared papersDLDon L. Gibbons3 shared papersNZNicolas Zhou3 shared papersJVJohn V. Heymach3 shared papersHLHeather Lin3 shared papersAWAnnikka Weissferdt2 shared papersAPApar Pataer2 shared papersHFHope Feldman2 shared papersASAnne S. Tsao2 shared papersKGK. G. Mitchell2 shared papers
Not generated yet